medical care

Future of the economy

Five 'pills' for biosimilars in Southeast Asia

As patents for innovator biologics have expired, biosimilars have emerged.

SGX Research Series: 10 in 10

Niche healthcare player Singapore Paincare Holdings gears up for broader market reach

Singapore Paincare Holdings is looking at a bigger target market. Find out more.

Broker's Calls

Singapore's well-insured ageing population makes this healthcare specialist a choice 'buy' pick

SINGAPORE (July 11): UOB Kay Hian is starting Asian Healthcare Specialists (AHS) at “buy” with a target price of 33 cents as it views the stock as a proxy to increased medical spending from Singapore’s ageing population and rising participation in s
×